Literature DB >> 1987537

Risks of alternate-day prednisone in patients with cystic fibrosis.

B J Rosenstein1, H Eigen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987537

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  26 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Recent advances in cystic fibrosis.

Authors:  G Santis; D Geddes
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

Review 3.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

4.  Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.

Authors:  A Rutman; R Dowling; P Wills; C Feldman; P J Cole; R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 5.  Role of corticosteroids in cystic fibrosis lung disease.

Authors:  I M Balfour-Lynn; R Dinwiddie
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

Review 6.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 7.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

Review 8.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Ibuprofen inhibits cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion.

Authors:  D C Devor; B D Schultz
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 10.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.